Respiratory Syncytial Virus (RSV) season typically begins on November 1st of each year and continues through March of the following year.
Effective immediately, Synagis (palivizumab) injections to prevent RSV may be provided by
any contracted provider
for Mercy Care and submitted with CPT Code
Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each.
Synagis (palivizumab) injections do not require prior authorization.
As always, don't hesitate to contact your
Provider Relations Representative with any questions or comments. You can find this notice and all other provider notices on our
We appreciate your continued assistance, support and cooperation!